USPTO serial 88491251
MISEQ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 21, 2020
- Examiner
- MEYERS, MORGAN LAURA
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MISEQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,700
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Diego, CA, US
San Diego, CA, US
San Diego, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan M. Natland
Susan M. Natland Baker & Hostetler LLP600 Anton Blvd, Suite 900Costa Mesa, CA 92626-7221United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for use in science and scientific research; diagnostic reagents and preparations, other than for medical or veterinary use; kits containing reagents and a protocol for use thereof for scientific and research purposes; biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics, not for medical or veterinary purposes; kits comprising nucleotides, reagents, enzyme substrates, buffers, chemical preparations, or biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics, not for medical or veterinary purposes | ACTIVE | Jul 26, 2011 |
| 005 | Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical and veterinary use; diagnostic reagents and preparations for medical and veterinary use, namely, for use in medical diagnostics; kits containing reagents and a protocol for use thereof for medical purposes; kits comprised of nucleotides, reagents, enzyme substrates, buffers, chemical preparations, biological preparations for medical genetic testing and medical diagnostic purposes; agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical and veterinary use in the fields of medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, genetic testing, and genetics | ACTIVE | Jul 26, 2011 |
| 009 | Laboratory devices for detecting genetic sequences; diagnostic apparatus for the detection of pathogens for laboratory or research use; scientific apparatus and instruments for use in genetic analysis; apparatus for DNA and RNA testing for research and scientific purposes; apparatus and instruments for testing gases, liquids, or solids in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, pharmaceuticals, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, genetic testing, and genetics; DNA chips; data processing apparatus; computers; computer monitors; computer hardware; downloadable and recorded computer software for sequencing and analysis of data in the field of DNA and RNA testing, genotyping, diagnostic research, and biotechnology; downloadable and recorded computer software for use in data analysis in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, genetic testing and genetics; Scientific and research apparatus and instruments namely, nucleic acid sequencers and sequencing reagent cartridges and trays; micro processors; data processors; next-generation sequencing (NGS) bioinformatics data processor; cards with integrated circuits; computer chips; encoded electronic chip cards containing programming used for DNA sequencing | ACTIVE | Jul 26, 2011 |
| 010 | Medical diagnostic apparatus and instruments for use in genetic analysis; medical diagnostic apparatus and instruments for the analysis of body fluids; apparatus for blood analysis; apparatus for DNA and RNA testing for medical purposes; medical and veterinary apparatus and instruments, namely for use in medical diagnostics for detecting genetic abnormalities and disease; analytical apparatus for medical purposes, namely apparatus that test and sequence genetic material for use in medical diagnostics; testing apparatus for medical purposes, for testing genetic material for use in medical diagnostics; medical diagnostic apparatus and instruments for use in preparing blood, bodily fluid and human biological samples for further testing and for the detection and identification of pathogen nucleic acids in blood, bodily fluids and biological samples; clinical and medical apparatus and instruments, including, nucleic acid sequencers; clinical and medical apparatus and instruments, namely, nucleic acid sequencers, nucleic acid analyzers, sample and library preparation devices for medical diagnosis, testing, and treatment purposes including in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, diagnostics, drug development, pharmaceuticals, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, genetic testing, and genetics | ACTIVE | Jul 26, 2011 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Illumina Inc.
- Other trademarks owned by Illumina, Inc.
- Other trademarks owned by Illumina, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named MISEQ
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 3, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 3, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 8, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 29, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 29, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 29, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 29, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 29, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 29, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 21, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 10, 2020 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Aug 10, 2020 | APET | ASSIGNED TO PETITION STAFF | — |
| Jul 21, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 25, 2020 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| May 5, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 5, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 26, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 21, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 20, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 21, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 18, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 21, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 8, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 1, 2019 | NWAP | NEW APPLICATION ENTERED | — |